Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1993-02-16
1994-10-11
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424 46, A61K 914
Patent
active
053545621
ABSTRACT:
Solid particle aerosol formulations of polypeptide drugs are made by lyophilizing solutions of the drugs which contain milling stabilizers that inhibit degradation of the drug during subsequent milling. The lyophilized drug is milled in fluid energy mills that have been fitted with abrasion-resistant materials and which use pure nitrogen that has been filtered to eliminate particles of greater than 0.1 .mu.m to transport the drug. The use of (a) milling stabilizers in the solution and (b) abrasion-resistant fluid energy mills that use pure filtered nitrogen in the milling step reduce insoluble contaminants and inactive fractions in the milled product.
REFERENCES:
patent: 4783484 (1988-11-01), Violante
patent: 4900734 (1990-02-01), Maxson
patent: 4940588 (1990-07-01), Sparks
patent: 5011678 (1991-04-01), Wang
patent: 5057321 (1991-10-01), Edgren
Pikal, M. J., "Freeze-Drying of Proteins, Part 1: Process Design", BioPharm (Sep. 1990) pp. 18-27.
Franks, F., "Freeze-Drying: From Empiricism to Predictability", Cryoletters (1990) 11:93-110.
Ip Anna
Platz Robert M.
Whitham Clyde L.
Benston, Jr. William E.
Cagan Felissa H.
Page Thurman K.
SRI - International
LandOfFree
Process for preparing micronized polypeptide drugs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for preparing micronized polypeptide drugs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing micronized polypeptide drugs will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1657080